-
N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
-
BD3009831206163-45-298+%
-
¥2855.0250mg
-
N-(5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
-
BD4486671142943-96-198%
-
¥160.01g
-
1-(Hydroxymethyl)cyclopropanecarboxamide
-
BD2783521123169-27-695%
-
¥2076.01g
-
N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)cyclopropanecarboxamide
-
BD010948401286230-87-298%
-
¥1086.01g
-
1-(Trifluoromethyl)cyclopropanecarboxamide
-
BD7581641628184-67-798%
-
¥1777.01g
-
N-(5-(4-((6-Cyanopyridin-3-yl)methoxy)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
-
BD2643481206101-20-399%
-
¥2954.025mg
-
N-(4-((4-Chloro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide
-
BD247548639090-55-495%
-
¥10285.01g
-
N-(6-(3-((N,N-Diethylsulfamoyl)amino)phenyl)-1H-indazol-3-yl)cyclopropanecarboxamide
-
BD011177552247894-32-097%
-
¥540.025mg
-
2-(4-Fluorophenyl)cyclopropanecarboxamide
-
BD6147091374509-48-497%
-
¥2467.01g
-
N-(Piperidin-4-yl)cyclopropanecarboxamide
-
BD01054285836685-68-895%
-
¥2903.01g
-
N-(5-(4-((1,1-Dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
-
BD3009791206161-97-899%
-
¥380.0100mg
-
N-(3-((4-((3-(Trifluoromethyl)phenyl)amino)pyrimidin-2-yl)amino)phenyl)cyclopropanecarboxamide
-
BD01091097879127-16-998%
-
¥899.050mg
-
N-(3-((6-((3-(Trifluoromethyl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)cyclopropanecarboxamide
-
BD01180250879127-07-898+%
-
¥697.010mg
-
N-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide
-
BD01279662882679-35-898%
-
¥4963.01g